Company Description
Materialise NV provides additive manufacturing and medical software tools, and 3D printing services in the Americas, Europe, Africa, and the Asia-Pacific.
The company operates through three segments: Materialise Software, Materialise Medical, and Materialise Manufacturing.
The Materialise Software segment offers software through programs and platforms that enable and enhance the functionality of 3D printers, and printing operations.
Its software interfaces between various types of 3D printers; and various software applications and capturing technologies, including computer-aided design/computer-aided manufacturing packages and 3D scanners; a MES, software providers.
This segment serves 3D printing machine manufacturers; production companies and contract manufacturers in automotive, aerospace, consumer goods, and hearing aid industries; and 3D printing service bureaus through its sales force, website, and third-party distributors.
The Materialise Medical segment provides medical software that allows medical-image based analysis, planning, and engineering, as well as patient-specific design and printing of surgical devices and implants.
It serves medical device companies, hospitals, universities, research institutes, and industrial companies through its direct sales force, website, and picture archiving and communication system.
The Materialise Manufacturing segment provides 3D printing services, design and engineering services, and rapid prototyping and additive manufacturing of production parts to customers serving the automotive, consumer goods industrial goods, semiconductor, art and architecture and aerospace markets.
The company has collaboration agreements with Zimmer Biomet Holdings, Inc.; Encore Medical, L.P.; DePuy Synthes Companies of Johnson & Johnson; Limacorporate Spa; Mathys AG; Smith & Nephew Inc.; Corin Ltd; Medtronic Inc.; and Abbott Laboratories Inc. Materialise NV was incorporated in 1990 and is headquartered in Leuven, Belgium.
| Country | Belgium |
| Founded | 1990 |
| IPO Date | Jun 25, 2014 |
| Industry | Software - Application |
| Sector | Technology |
| Employees | 488 |
| CEO | Brigitte de Vet-Veithen |
Contact Details
Address: Technologielaan 15 Leuven, 3001 Belgium | |
| Phone | 32 1 639 66 11 |
| Website | materialise.com |
Stock Details
| Ticker Symbol | MTLS |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | EUR |
| CIK Code | 0001091223 |
| CUSIP Number | 57667T100 |
| ISIN Number | US57667T1007 |
| SIC Code | 7372 |
Key Executives
| Name | Position |
|---|---|
| Brigitte de Vet-Veithen | Chief Executive Officer |
| Wilfried Vancraen | Founder and Chairman |
| Koen Berges | Chief Financial Officer |
| Johan Pauwels | Executive Vice President and Chief Operating Officer |
| Bart Van der Schueren | Chief Strategy and Technology Officer and Executive Vice President |
| Carla Van Steenbergen | Director of Corporate Affairs, Vice President, Compliance Officer and Secretary |
| Conny Hooghe | Global Human Resources Director |
| Jurgen Laudus | Executive Vice President of Manufacturing |
| Udo Eberlein | Executive Vice President of Software |
| Koen Peters | Executive Vice President of Medical |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Jul 24, 2025 | 6-K | Report of foreign issuer |
| Jul 24, 2025 | 6-K | Report of foreign issuer |
| Jun 12, 2025 | 6-K | Report of foreign issuer |
| May 16, 2025 | 6-K | Report of foreign issuer |
| May 13, 2025 | SD | Form - SD |
| Apr 24, 2025 | 6-K | Report of foreign issuer |
| Apr 24, 2025 | 6-K | Report of foreign issuer |
| Apr 22, 2025 | S-8 POS | Securities to be offered to employees in employee benefit plans, post-effective amendments |
| Apr 22, 2025 | S-8 | Securities to be offered to employees in employee benefit plans |
| Apr 22, 2025 | 20-F | Annual and transition report of foreign private issuers |